Your browser doesn't support javascript.
loading
Prognostic value of NOX2 as a potential biomarker for lung adenocarcinoma using TCGA and clinical validation.
Liu, Yingjie; Han, Di; Ma, Qihui; Zheng, Yuanhang; Lin, Yi; Yang, Chunqing; Yang, Lun.
Affiliation
  • Liu Y; College of Medical Laboratory, Weifang Medical University, Weifang, Shandong 261000, P.R. China.
  • Han D; Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong 266071, P.R. China.
  • Ma Q; College of Medical Laboratory, Weifang Medical University, Weifang, Shandong 261000, P.R. China.
  • Zheng Y; College of Medical Laboratory, Weifang Medical University, Weifang, Shandong 261000, P.R. China.
  • Lin Y; Department of Pathology, The People's Hospital of Fangzi District, Weifang, Shandong 261000, P.R. China.
  • Yang C; College of Medical Laboratory, Weifang Medical University, Weifang, Shandong 261000, P.R. China.
  • Yang L; Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Mol Med Rep ; 27(2)2023 Feb.
Article in En | MEDLINE | ID: mdl-36633128

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Biomarkers, Tumor / NADPH Oxidase 2 / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Mol Med Rep Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Biomarkers, Tumor / NADPH Oxidase 2 / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Mol Med Rep Year: 2023 Document type: Article